0001656472-24-000042.txt : 20240319 0001656472-24-000042.hdr.sgml : 20240319 20240319170748 ACCESSION NUMBER: 0001656472-24-000042 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shlimak Anna CENTRAL INDEX KEY: 0001804953 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 24764842 MAIL ADDRESS: STREET 1: 720 KING STREET WEST, SUITE 320 CITY: TORONTO STATE: A6 ZIP: M5V 2T3 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 4 1 wk-form4_1710882454.xml FORM 4 X0508 4 2024-03-15 0 0001656472 Cronos Group Inc. CRON 0001804953 Shlimak Anna 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2H1 ONTARIO, CANADA 0 1 0 0 See Remarks 0 COMMON SHARES 2024-03-15 4 M 0 30000 0 A 147845 D COMMON SHARES 2024-03-15 4 F 0 8895 1.98 D 138950 D COMMON SHARES 2024-03-15 4 M 0 45226 0 A 184176 D COMMON SHARES 2024-03-15 4 F 0 11799 1.98 D 172377 D RESTRICTED STOCK UNITS 2024-03-15 4 M 0 30000 0 D COMMON SHARES 30000 302733 D RESTRICTED STOCK UNITS 2024-03-15 4 M 0 45226 0 D COMMON SHARES 45226 257507 D Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc. On March 15, 2022, the Reporting Person was granted 90,000 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. On March 15, 2023, the Reporting Person was granted 135,678 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Senior Vice President, Corporate Affairs and Strategy /s/ Aaron Werner, as attorney-in-fact for Anna Shlimak 2024-03-19